Buyer
DAK-Gesundheit
Open — accepting bids
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tafluprost + Timolol, ATC S01ED70 für die Zeit 01.09.2025 - 31.08.2027
DAK-Gesundheit · Germany
⏳ Closes 05 Jul 2027 — 276 days left
Location
Germany
Category
Cn Standard
Type
—
Estimated value
—
EMD / Bid security
—
Tender fee
—
Published
—
Closing
05 Jul 2027
Reference
—
Can your company win this tender?
askTender reads every tender against your company profile — eligibility, gaps, and the documents you need — and can prepare the entire bid for you.
Check your fit — free →Eligibility
Full eligibility criteria are in the tender document. Sign in to read this tender against your company profile.
About this tender
https://ted.europa.eu/en/notice/467526-2025/xml